ORIC — ORIC Pharmaceuticals, Inc.

Ownership history in SR ONE CAPITAL MANAGEMENT, LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which SR ONE CAPITAL MANAGEMENT, LP reported a position in ORIC Pharmaceuticals, Inc. (ORIC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
9.93% (2025 Q2)
Avg. % of fund
7.7%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 4,514,929 — 0% 5.34% $37.8M $8.18
2025 Q3 UNCHANGED 4,514,929 — 0% 7.84% $54.2M $12.00
2025 Q2 INITIATED 4,514,929 — — 9.93% $45.8M $10.15
% of Fund (quarterly)    ORIC price (monthly, adj. close)

Other funds also holding ORIC

As of 2025 Q4 — sorted by position size

Column Group LLC 3Y 34.98% PFIZER INC 18.6% EcoR1 Capital, LLC 3Y 7Y 2.5% VR Adviser, LLC 3Y 2.29% Euclidean Capital LLC 3Y 2.19% First Turn Management, LLC 1.88% NEA Management Company, LLC 3Y 7Y 1.72% MPM BioImpact LLC 3Y 1.68% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.59% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 1.27%
← Back to SR ONE CAPITAL MANAGEMENT, LP Holdings